Selected research
Market Outlook & Growth Opportunities
Global Veterinary Blood Products Market Outlook and Growth Opportunities 2026
Market perspective
The global Veterinary Blood Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Veterinary Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Veterinary Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Veterinary Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Veterinary Blood Products market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Veterinary Blood Products market include Animal Blood Resources International (ABRI), Hemopet, BluePearl Pet Blood Bank, VETSTEM Biopharma, Pet Blood Bank UK, Royal Veterinary College (RVC) Blood Donor Program, Lampire Biological Laboratories, Plasvacc USA and Innovative Research, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Veterinary Blood Products market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Veterinary Blood Products and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Veterinary Blood Products sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Veterinary Blood Products market size, projected growth trends, production technologies, key applications, and end-use industries.
Veterinary Blood Products Segment by Company
Animal Blood Resources International (ABRI)
Hemopet
BluePearl Pet Blood Bank
VETSTEM Biopharma
Pet Blood Bank UK
Royal Veterinary College (RVC) Blood Donor Program
Lampire Biological Laboratories
Plasvacc USA
Innovative Research
HemoStat Laboratories
TCS Biosciences
Pel-Freez Biologicals
SSI Diagnostica
BioChemed
Serana Europe
NZCABB
Veterinary Blood Products Segment by Type
Whole Blood
Concentrated Red Blood Cells
Fresh Frozen Plasma
Others
Veterinary Blood Products Segment by Application
Animal Hospital
Animal Clinic
Veterinary Blood Products Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Veterinary Blood Products status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Veterinary Blood Products market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Veterinary Blood Products significant trends, drivers, influence factors in global and regions.
6. To analyze Veterinary Blood Products competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Blood Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Blood Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Blood Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Veterinary Blood Products market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Veterinary Blood Products industry.
Chapter 3: Detailed analysis of Veterinary Blood Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Veterinary Blood Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Veterinary Blood Products in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Whole Blood
- Concentrated Red Blood Cells
- Fresh Frozen Plasma
- Others
Applications
- Animal Hospital
- Animal Clinic
Companies covered
- Animal Blood Resources International (ABRI)
- Hemopet
- BluePearl Pet Blood Bank
- VETSTEM Biopharma
- Pet Blood Bank UK
- Royal Veterinary College (RVC) Blood Donor Program
- Lampire Biological Laboratories
- Plasvacc USA
- Innovative Research
- HemoStat Laboratories
- TCS Biosciences
- Pel-Freez Biologicals
- SSI Diagnostica
- BioChemed
- Serana Europe
- NZCABB
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Veterinary Blood Products Sales Value (2021-2032)
- 1.2.2 Global Veterinary Blood Products Sales Volume (2021-2032)
- 1.2.3 Global Veterinary Blood Products Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Veterinary Blood Products Market Dynamics
- 2.1 Veterinary Blood Products Industry Trends
- 2.2 Veterinary Blood Products Industry Drivers
- 2.3 Veterinary Blood Products Industry Opportunities and Challenges
- 2.4 Veterinary Blood Products Industry Restraints
3 Veterinary Blood Products Market by Company
- 3.1 Global Veterinary Blood Products Company Revenue Ranking in 2025
- 3.2 Global Veterinary Blood Products Revenue by Company (2021-2026)
- 3.3 Global Veterinary Blood Products Sales Volume by Company (2021-2026)
- 3.4 Global Veterinary Blood Products Average Price by Company (2021-2026)
- 3.5 Global Veterinary Blood Products Company Ranking (2024-2026)
- 3.6 Global Veterinary Blood Products Company Manufacturing Base and Headquarters
- 3.7 Global Veterinary Blood Products Company Product Type and Application
- 3.8 Global Veterinary Blood Products Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Veterinary Blood Products Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Veterinary Blood Products Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Veterinary Blood Products Market by Type
- 4.1 Veterinary Blood Products Type Introduction
- 4.1.1 Whole Blood
- 4.1.2 Concentrated Red Blood Cells
- 4.1.3 Fresh Frozen Plasma
- 4.1.4 Others
- 4.2 Global Veterinary Blood Products Sales Volume by Type
- 4.2.1 Global Veterinary Blood Products Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Veterinary Blood Products Sales Volume by Type (2021-2032)
- 4.2.3 Global Veterinary Blood Products Sales Volume Share by Type (2021-2032)
- 4.3 Global Veterinary Blood Products Sales Value by Type
- 4.3.1 Global Veterinary Blood Products Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Veterinary Blood Products Sales Value by Type (2021-2032)
- 4.3.3 Global Veterinary Blood Products Sales Value Share by Type (2021-2032)
5 Veterinary Blood Products Market by Application
- 5.1 Veterinary Blood Products Application Introduction
- 5.1.1 Animal Hospital
- 5.1.2 Animal Clinic
- 5.2 Global Veterinary Blood Products Sales Volume by Application
- 5.2.1 Global Veterinary Blood Products Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Veterinary Blood Products Sales Volume by Application (2021-2032)
- 5.2.3 Global Veterinary Blood Products Sales Volume Share by Application (2021-2032)
- 5.3 Global Veterinary Blood Products Sales Value by Application
- 5.3.1 Global Veterinary Blood Products Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Veterinary Blood Products Sales Value by Application (2021-2032)
- 5.3.3 Global Veterinary Blood Products Sales Value Share by Application (2021-2032)
6 Veterinary Blood Products Regional Sales and Value Analysis
- 6.1 Global Veterinary Blood Products Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Veterinary Blood Products Sales by Region (2021-2032)
- 6.2.1 Global Veterinary Blood Products Sales by Region: 2021-2026
- 6.2.2 Global Veterinary Blood Products Sales by Region (2027-2032)
- 6.3 Global Veterinary Blood Products Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Veterinary Blood Products Sales Value by Region (2021-2032)
- 6.4.1 Global Veterinary Blood Products Sales Value by Region: 2021-2026
- 6.4.2 Global Veterinary Blood Products Sales Value by Region (2027-2032)
- 6.5 Global Veterinary Blood Products Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Veterinary Blood Products Sales Value (2021-2032)
- 6.6.2 North America Veterinary Blood Products Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Veterinary Blood Products Sales Value (2021-2032)
- 6.7.2 Europe Veterinary Blood Products Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Veterinary Blood Products Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Veterinary Blood Products Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Veterinary Blood Products Sales Value (2021-2032)
- 6.9.2 South America Veterinary Blood Products Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Veterinary Blood Products Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Veterinary Blood Products Sales Value Share by Country, 2025 VS 2032
7 Veterinary Blood Products Country-level Sales and Value Analysis
- 7.1 Global Veterinary Blood Products Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Veterinary Blood Products Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Veterinary Blood Products Sales by Country (2021-2032)
- 7.3.1 Global Veterinary Blood Products Sales by Country (2021-2026)
- 7.3.2 Global Veterinary Blood Products Sales by Country (2027-2032)
- 7.4 Global Veterinary Blood Products Sales Value by Country (2021-2032)
- 7.4.1 Global Veterinary Blood Products Sales Value by Country (2021-2026)
- 7.4.2 Global Veterinary Blood Products Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Veterinary Blood Products Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Veterinary Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Veterinary Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Veterinary Blood Products Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Veterinary Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Veterinary Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Veterinary Blood Products Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Veterinary Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Veterinary Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Veterinary Blood Products Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Veterinary Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Veterinary Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Veterinary Blood Products Sales Value Growth Rate (2021-2032)
- 7.9.2 France Veterinary Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Veterinary Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Veterinary Blood Products Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Veterinary Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Veterinary Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Veterinary Blood Products Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Veterinary Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Veterinary Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Veterinary Blood Products Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Veterinary Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Veterinary Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Veterinary Blood Products Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Veterinary Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Veterinary Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Veterinary Blood Products Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Veterinary Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Veterinary Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Veterinary Blood Products Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Veterinary Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Veterinary Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Veterinary Blood Products Sales Value Growth Rate (2021-2032)
- 7.16.2 China Veterinary Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Veterinary Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Veterinary Blood Products Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Veterinary Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Veterinary Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Veterinary Blood Products Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Veterinary Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Veterinary Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Veterinary Blood Products Sales Value Growth Rate (2021-2032)
- 7.19.2 India Veterinary Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Veterinary Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Veterinary Blood Products Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Veterinary Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Veterinary Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Veterinary Blood Products Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Veterinary Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Veterinary Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Veterinary Blood Products Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Veterinary Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Veterinary Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Veterinary Blood Products Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Veterinary Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Veterinary Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Veterinary Blood Products Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Veterinary Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Veterinary Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Veterinary Blood Products Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Veterinary Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Veterinary Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Veterinary Blood Products Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Veterinary Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Veterinary Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Veterinary Blood Products Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Veterinary Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Veterinary Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Veterinary Blood Products Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Veterinary Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Veterinary Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Veterinary Blood Products Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Veterinary Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Veterinary Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Veterinary Blood Products Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Veterinary Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Veterinary Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Veterinary Blood Products Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Veterinary Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Veterinary Blood Products Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Veterinary Blood Products Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Veterinary Blood Products Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Veterinary Blood Products Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Animal Blood Resources International (ABRI)
- 8.1.1 Animal Blood Resources International (ABRI) Company Information
- 8.1.2 Animal Blood Resources International (ABRI) Business Overview
- 8.1.3 Animal Blood Resources International (ABRI) Veterinary Blood Products Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Animal Blood Resources International (ABRI) Veterinary Blood Products Product Portfolio
- 8.1.5 Animal Blood Resources International (ABRI) Recent Developments
- 8.2 Hemopet
- 8.2.1 Hemopet Company Information
- 8.2.2 Hemopet Business Overview
- 8.2.3 Hemopet Veterinary Blood Products Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Hemopet Veterinary Blood Products Product Portfolio
- 8.2.5 Hemopet Recent Developments
- 8.3 BluePearl Pet Blood Bank
- 8.3.1 BluePearl Pet Blood Bank Company Information
- 8.3.2 BluePearl Pet Blood Bank Business Overview
- 8.3.3 BluePearl Pet Blood Bank Veterinary Blood Products Sales, Value and Gross Margin (2021-2026)
- 8.3.4 BluePearl Pet Blood Bank Veterinary Blood Products Product Portfolio
- 8.3.5 BluePearl Pet Blood Bank Recent Developments
- 8.4 VETSTEM Biopharma
- 8.4.1 VETSTEM Biopharma Company Information
- 8.4.2 VETSTEM Biopharma Business Overview
- 8.4.3 VETSTEM Biopharma Veterinary Blood Products Sales, Value and Gross Margin (2021-2026)
- 8.4.4 VETSTEM Biopharma Veterinary Blood Products Product Portfolio
- 8.4.5 VETSTEM Biopharma Recent Developments
- 8.5 Pet Blood Bank UK
- 8.5.1 Pet Blood Bank UK Company Information
- 8.5.2 Pet Blood Bank UK Business Overview
- 8.5.3 Pet Blood Bank UK Veterinary Blood Products Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Pet Blood Bank UK Veterinary Blood Products Product Portfolio
- 8.5.5 Pet Blood Bank UK Recent Developments
- 8.6 Royal Veterinary College (RVC) Blood Donor Program
- 8.6.1 Royal Veterinary College (RVC) Blood Donor Program Company Information
- 8.6.2 Royal Veterinary College (RVC) Blood Donor Program Business Overview
- 8.6.3 Royal Veterinary College (RVC) Blood Donor Program Veterinary Blood Products Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Royal Veterinary College (RVC) Blood Donor Program Veterinary Blood Products Product Portfolio
- 8.6.5 Royal Veterinary College (RVC) Blood Donor Program Recent Developments
- 8.7 Lampire Biological Laboratories
- 8.7.1 Lampire Biological Laboratories Company Information
- 8.7.2 Lampire Biological Laboratories Business Overview
- 8.7.3 Lampire Biological Laboratories Veterinary Blood Products Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Lampire Biological Laboratories Veterinary Blood Products Product Portfolio
- 8.7.5 Lampire Biological Laboratories Recent Developments
- 8.8 Plasvacc USA
- 8.8.1 Plasvacc USA Company Information
- 8.8.2 Plasvacc USA Business Overview
- 8.8.3 Plasvacc USA Veterinary Blood Products Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Plasvacc USA Veterinary Blood Products Product Portfolio
- 8.8.5 Plasvacc USA Recent Developments
- 8.9 Innovative Research
- 8.9.1 Innovative Research Company Information
- 8.9.2 Innovative Research Business Overview
- 8.9.3 Innovative Research Veterinary Blood Products Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Innovative Research Veterinary Blood Products Product Portfolio
- 8.9.5 Innovative Research Recent Developments
- 8.10 HemoStat Laboratories
- 8.10.1 HemoStat Laboratories Company Information
- 8.10.2 HemoStat Laboratories Business Overview
- 8.10.3 HemoStat Laboratories Veterinary Blood Products Sales, Value and Gross Margin (2021-2026)
- 8.10.4 HemoStat Laboratories Veterinary Blood Products Product Portfolio
- 8.10.5 HemoStat Laboratories Recent Developments
- 8.11 TCS Biosciences
- 8.11.1 TCS Biosciences Company Information
- 8.11.2 TCS Biosciences Business Overview
- 8.11.3 TCS Biosciences Veterinary Blood Products Sales, Value and Gross Margin (2021-2026)
- 8.11.4 TCS Biosciences Veterinary Blood Products Product Portfolio
- 8.11.5 TCS Biosciences Recent Developments
- 8.12 Pel-Freez Biologicals
- 8.12.1 Pel-Freez Biologicals Company Information
- 8.12.2 Pel-Freez Biologicals Business Overview
- 8.12.3 Pel-Freez Biologicals Veterinary Blood Products Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Pel-Freez Biologicals Veterinary Blood Products Product Portfolio
- 8.12.5 Pel-Freez Biologicals Recent Developments
- 8.13 SSI Diagnostica
- 8.13.1 SSI Diagnostica Company Information
- 8.13.2 SSI Diagnostica Business Overview
- 8.13.3 SSI Diagnostica Veterinary Blood Products Sales, Value and Gross Margin (2021-2026)
- 8.13.4 SSI Diagnostica Veterinary Blood Products Product Portfolio
- 8.13.5 SSI Diagnostica Recent Developments
- 8.14 BioChemed
- 8.14.1 BioChemed Company Information
- 8.14.2 BioChemed Business Overview
- 8.14.3 BioChemed Veterinary Blood Products Sales, Value and Gross Margin (2021-2026)
- 8.14.4 BioChemed Veterinary Blood Products Product Portfolio
- 8.14.5 BioChemed Recent Developments
- 8.15 Serana Europe
- 8.15.1 Serana Europe Company Information
- 8.15.2 Serana Europe Business Overview
- 8.15.3 Serana Europe Veterinary Blood Products Sales, Value and Gross Margin (2021-2026)
- 8.15.4 Serana Europe Veterinary Blood Products Product Portfolio
- 8.15.5 Serana Europe Recent Developments
- 8.16 NZCABB
- 8.16.1 NZCABB Company Information
- 8.16.2 NZCABB Business Overview
- 8.16.3 NZCABB Veterinary Blood Products Sales, Value and Gross Margin (2021-2026)
- 8.16.4 NZCABB Veterinary Blood Products Product Portfolio
- 8.16.5 NZCABB Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Veterinary Blood Products Value Chain Analysis
- 9.1.1 Veterinary Blood Products Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Veterinary Blood Products Sales Mode & Process
- 9.2 Veterinary Blood Products Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Veterinary Blood Products Distributors
- 9.2.3 Veterinary Blood Products Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst